PCM
MRTX

Pentwater Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Pentwater Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-902,632
Closed -$53M – 101
2023
Q4 		$53M Buy
+902,632
New +$53M 0.59% 19